Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.770
+0.041 (2.37%)
Jun 12, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 699.66 million as of June 12, 2026. Its market cap has increased by 66.44% in one year.
Market Cap
699.66M
Enterprise Value
625.30M
Revenue
83.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.77
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 699.66M, a decrease of -58.09%. That is a compound annual growth rate of -8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 699.66M | -46.61% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 930.82M |
| Infant Bacterial Therapeutics AB | 821.76M |
| SynAct Pharma AB | 771.60M |
| FluoGuide | 721.00M |
| Xspray Pharma AB | 717.89M |
| Cantargia AB | 537.00M |
| AlzeCure Pharma AB | 491.83M |